Retatrutide (LY3437943) is one of the most significant developments in metabolic peptide research in decades. As a triple agonist of the GLP-1, GIP, and glucagon receptors simultaneously, it occupies a unique mechanistic space that distinguishes it from semaglutide (GLP-1 only) and tirzepatide (GLP-1/GIP dual). For a deeper scientific overview of the compound's mechanisms, see our Retatrutide research overview. For researchers in Malaysia studying obesity, insulin resistance, or metabolic syndrome, Retatrutide is now accessible locally through Concept Peptides without the complications of international ordering.
Note: Retatrutide is a research compound currently in Phase 3 clinical development. It is not approved for human use. All purchases from Concept Peptides are for research and laboratory purposes only.
What Makes Retatrutide Different?
Triple Receptor Mechanism
Most GLP-1 based compounds work primarily through appetite suppression and delayed gastric emptying. Retatrutide adds two additional layers:
- GIP receptor agonism: Enhances insulin secretion, improves beta-cell function, and appears to act synergistically with GLP-1 to amplify satiety signals in the brain.
- Glucagon receptor agonism: Drives thermogenesis (heat production) and hepatic fat oxidation β effects that neither semaglutide nor tirzepatide provide. This explains the additional metabolic clearance seen in Retatrutide's Phase 2 data.
Phase 2 Trial Results
Data published in the New England Journal of Medicine (2023) from Eli Lilly's Phase 2 trial showed subjects in the highest dose group (12mg weekly) achieving an average 24.2% reduction in body weight at 48 weeks β the highest figure recorded for any anti-obesity drug at Phase 2. In comparison, semaglutide achieves approximately 15% and tirzepatide approximately 22.5% at maximum doses. For researchers benchmarking the relative efficacy of these receptor pathways, these figures are significant data points.
Hepatic Fat and Metabolic Parameters
Beyond weight reduction, Retatrutide's glucagon agonism drives measurable reductions in liver fat content β an important parameter in non-alcoholic fatty liver disease (NAFLD) research. Phase 2 participants also showed improvements in fasting insulin, HbA1c, triglycerides, and waist circumference, suggesting broad metabolic improvements beyond weight alone.
How to Buy Retatrutide in Malaysia
Local vs Overseas Sourcing
Retatrutide research peptide sourced from overseas typically arrives in 3β5 weeks and involves customs risk. As a Malaysia-based supplier, Concept Peptides ships Retatrutide domestically with 1β3 business day delivery and no import complications. All batches are accompanied by a third-party Certificate of Analysis confirming sequence accuracy and purity.
What Format Is It Supplied In?
Concept Peptides supplies Retatrutide as a lyophilised (freeze-dried) powder in sealed research vials. This is the standard format for peptide research β lyophilisation preserves stability and extends shelf life. It is reconstituted with BAC Water prior to use. A free BAC Water vial is included with every Retatrutide order.
Purity Verification
Given Retatrutide's complexity as a larger peptide, purity verification is essential. Every batch is independently tested by a third-party laboratory and a Certificate of Analysis (COA) is available upon request, confirming the amino acid sequence, molecular weight, and purity percentage by HPLC.
Frequently Asked Questions
What is Retatrutide used for in research?
Retatrutide is used in preclinical and research settings to study the GLP-1, GIP, and glucagon receptor pathways β particularly their combined effects on energy balance, adipose tissue, hepatic fat metabolism, insulin secretion, and body composition.
How does Retatrutide compare to semaglutide?
Semaglutide is a GLP-1 receptor agonist only. Retatrutide adds GIP and glucagon receptor agonism, producing additional thermogenic and hepatic fat-clearing effects not seen with GLP-1 alone. Phase 2 data shows greater weight reduction with Retatrutide at its highest doses. For a broader look at GLP-1 class compounds available for Malaysian researchers, see our GLP-1 peptides Malaysia guide, and for a comparison of the leading weight-loss peptides, see our overview of the best peptides for weight loss Malaysia.
Is Retatrutide available in Malaysia?
Yes β Concept Peptides stocks Retatrutide in lyophilised research-grade format, available for order with local payment methods and domestic shipping throughout Malaysia.
References
- Jastreboff AM, et al. "Triple-Hormone-Receptor Agonist Retatrutide for Obesity β A Phase 2 Trial." New England Journal of Medicine. 2023;389(6):514β526.